Phase III prospective randomized comparison trial of depot octreotide plus interferon Alfa-2b versus depot octreotide plus bevacizumab in patients with advanced carcinoid tumors: SWOG S0518

James C. Yao, Cesar Moran, Katherine A. Guthrie, Shannon McDonough, Jonathan R. Strosberg, Matthew H. Kulke, Jennifer A. Chan, Noelle Loconte, Robert R. McWilliams, Edward M. Wolin, Edward M. Wolin, Bassam Mattar, Helen Chen, Charles D. Blanke, Howard S. Hochster

Research output: Contribution to journalArticle

53 Scopus citations

Fingerprint Dive into the research topics of 'Phase III prospective randomized comparison trial of depot octreotide plus interferon Alfa-2b versus depot octreotide plus bevacizumab in patients with advanced carcinoid tumors: SWOG S0518'. Together they form a unique fingerprint.

Medicine & Life Sciences